Top Midday Stories: Merck to Acquire Cidara Therapeutics for $9.2 Billion; Walmart Names John Furner as CEO

MT Newswires Live
Nov 15

The S&P 500 and Nasdaq Composite rose in midday trading, erasing earlier declines, and the Dow Jones Industrial Average eased.

In company news, Merck (MRK) agreed to acquire Cidara Therapeutics (CDTX) for $9.2 billion, or $221.50 a share in cash. The transaction is expected to close in Q1 2026. Merck shares rose 1.5% at midday, and Cidara more than doubled.

Walmart (WMT) said its board elected John Furner as president and chief executive officer, effective Feb. 1, 2026. Furner will succeed Doug McMillon, who will retire on Jan. 31 and remain on the board until the next annual shareholders meeting. Furner has served as president and CEO of Walmart US since 2019. Walmart shares fell 1.4%.

Applied Materials (AMAT) reported fiscal Q4 adjusted earnings late Thursday of $2.17 per diluted share, down from $2.32 a year earlier. Analysts polled by FactSet expected $2.11. Revenue in the three months ended Oct. 26 fell to $6.8 billion from $7.05 billion. Analysts projected $6.68 billion. The company expects Q1 adjusted EPS of $2.18 on revenue of $6.85 billion. Analysts forecast EPS of $2.14 on revenue of $6.79 billion. Applied Materials shares edged up 0.1% at midday.

StubHub Holdings (STUB) reported a Q3 loss late Thursday of $4.27 per diluted share, widening from the loss of $0.15 a year earlier. Analysts polled by FactSet expected a loss of $2.87. Revenue rose to $468.1 million from $433.8 million. Analysts projected $451.8 million. StubHub shares tumbled 20% at midday after the company withheld guidance.

Price: 94.29, Change: +1.35, Percent Change: +1.46

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10